Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it’s inferior.
Viking’s 42% Plunge Splits Experts—A ‘$129 Strong Buy’ Or ‘Clearly Inferior’ Drug?
Where Today's News Shapes Tomorrow
